Jane Street’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding PGNX
FCM
TA
Jane Street's PGNX Position: Q1 2020 in Review
Jane Street sold out of Progenics Pharmaceuticals Inc (PGNX) in Q1 2020, closing a stake of 12,178 shares — an estimated $62K sold.
Jane Street first reported a position in PGNX in Q2 2013 and held it in 13 quarters. The position peaked at $476K in Q1 2017. 129 funds tracked by Wall St. Rank hold PGNX as of Q1 2020.
- Jane Street reported no remaining Progenics Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
- Jane Street sold 12,178 Progenics Pharmaceuticals Inc shares in Q1 2020, an estimated $62K.
- Jane Street first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 13 quarters.
- Jane Street's Progenics Pharmaceuticals Inc position peaked at $476K in Q1 2017.
- 129 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q1 2020.
Based on Jane Street's 13F filing for Q1 2020, filed 15 May 2020.